Cyclacel Pharmaceuticals ... (CYCC)

NASDAQ: CYCC · Real-Time Price · USD

0.26

-0.04 (-14.42%)

At close: Apr 30, 2025, 3:59 PM

0.26

0.85%

After-hours: Apr 30, 2025, 05:36 PM EDT

Cyclacel Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	43K	420K	n/a	n/a	n/a	n/a	150K	n/a	843K
Cost of Revenue	n/a	n/a	32K	43K	20K	20K	4.33M	32K	9.48M
Gross Profit	43K	420K	-32K	-43K	-20K	-20K	-4.18M	-32K	-8.63M
Operating Income	-12M	-25.45M	-27.66M	-22.94M	-10.64M	-9.68M	-9.55M	-9.49M	-14.15M
Interest Income	12K	266K	210K	16K	42K	224K	331K	118K	37K
Pretax Income	-11.99M	-25.55M	-25.91M	-22.73M	-9.68M	-9.13M	-8.63M	-8.46M	-13.77M
Net Income	-11.21M	-22.55M	-21.2M	-18.89M	-8.45M	-7.83M	-7.29M	-7.47M	-11.79M
Selling & General & Admin	5.39M	6.72M	7.38M	7.46M	5.88M	5.02M	5.37M	5.25M	5.52M
Research & Development	6.66M	19.16M	20.27M	15.48M	4.76M	4.66M	4.33M	4.24M	9.48M
Other Expenses	n/a	n/a	1.3M	144K	891K	231K	682K	949K	n/a
Operating Expenses	12.05M	25.87M	27.66M	22.94M	10.64M	9.68M	9.7M	9.49M	14.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	12.05M	25.87M	27.66M	22.94M	10.64M	9.68M	9.7M	9.49M	14.99M
Income Tax Expense	-782K	-3M	-4.72M	-3.85M	-1.24M	-1.3M	-1.34M	-993K	-1.98M
Shares Outstanding (Basic)	2.15M	1.7M	1.5M	1.19M	484.45K	401.41K	401.41K	401.41K	22.83K
Shares Outstanding (Diluted)	2.15M	1.7M	1.5M	1.19M	484.45K	401.41K	401.41K	401.41K	22.83K
EPS (Basic)	-5.21	-13.26	-14.13	-15.87	-17.43	-19.5	-18.16	-18.61	-516.42
EPS (Diluted)	-5.21	-13.26	-14.13	-15.87	-17.43	-19.5	-18.16	-18.61	-516.42
EBITDA	-12M	-25.42M	-27.62M	-22.69M	-10.62M	-9.66M	-9.52M	-9.46M	-14.02M
EBIT	-12M	-25.45M	-27.66M	-22.73M	-10.64M	-9.68M	-9.55M	-9.49M	-14.15M
Depreciation & Amortization	6K	31K	32K	43K	20K	20K	29K	32K	133K